Patents by Inventor Debasis MONDAL

Debasis MONDAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11357866
    Abstract: A composition of matter and method of treating HIV with mesenchymal stem cells (MSC) is disclosed. Specifically, MSCs are transduced with vectors incorporating an anti-viral fusion inhibitor, such as a C46-derived peptide or neutralizing antibody. The transduced MSCs are capable of expression the inhibitor and preventing HIV virus-cell fusion.
    Type: Grant
    Filed: June 7, 2018
    Date of Patent: June 14, 2022
    Assignee: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
    Inventors: Stephen E. Braun, Debasis Mondal, Bruce A Bunnell, Narae Lee
  • Publication number: 20180280538
    Abstract: A composition of matter and method of treating HIV with mesenchymal stem cells (MSC) is disclosed. Specifically, MSCs are transduced with vectors incorporating an anti-viral fusion inhibitor, such as a C46-derived peptide or neutralizing antibody. The transduced MSCs are capable of expression the inhibitor and preventing HIV virus-cell fusion.
    Type: Application
    Filed: June 7, 2018
    Publication date: October 4, 2018
    Inventors: Stephen E. BRAUN, Debasis MONDAL, Bruce A. BUNNELL, Narae LEE
  • Publication number: 20160060302
    Abstract: A composition of matter and method of treating HIV with mesenchymal stem cells (MSC) is disclosed. Specifically, MSCs are transduced with vectors incorporating an anti-viral fusion inhibitor, such as a C46-derived peptide. The transduced MSCs are capable of expression the inhibitor and preventing HIV virus-cell fusion.
    Type: Application
    Filed: April 3, 2014
    Publication date: March 3, 2016
    Inventors: Stephen E. BRAUN, Debasis MONDAL, Bruce A BUNNEL, Narae LEE